Erwin W Gelfand Selected Research

Inflammation

04/2008	Corticosteroids enhance CD8(+) T cell-mediated airway hyperresponsiveness and allergic inflammation by upregulating leukotriene B(4) receptor 1.
01/2008	The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines.
01/2008	Growth factors temporally associate with airway responsiveness and inflammation in allergen-exposed mice.
07/2007	Arhgef1 is required by T cells for the development of airway hyperreactivity and inflammation.
01/2007	Critical role of the Fc receptor gamma-chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation.
09/2006	Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge.
06/2006	Role of the LTB4/BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation.
05/2006	Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation.
04/2005	Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling.
05/2004	Aerosolized anti-T-cell-receptor antibodies are effective against airway inflammation and hyperreactivity.
03/2004	Different potentials of gamma delta T cell subsets in regulating airway responsiveness: V gamma 1+ cells, but not V gamma 4+ cells, promote airway hyperreactivity, Th2 cytokines, and airway inflammation.
02/2004	Contribution of antigen-primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13.
10/2003	Effects of fexofenadine on T-cell function in a murine model of allergen-induced airway inflammation and hyperresponsiveness.
10/2003	Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function.
11/2002	Effect of microbial heat shock proteins on airway inflammation and hyperresponsiveness.
07/2002	Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness.

Articles by Research Topic

Disease

16	Inflammation 04/2008 - 07/2002
5	Asthma (Bronchial Asthma) 04/2006 - 12/2002
2	Rhinitis 11/2006 - 11/2005
2	Infection 08/2005 - 04/2005
1	Opportunistic Infections (Opportunistic Infection) 04/2008
1	Severe Combined Immunodeficiency (SCID) 06/2007
1	Airway Obstruction (Choking) 09/2006
1	Deficiency Diseases (Deficiency Disease) 03/2005
1	Neoplasms (Cancer) 09/2003

Drug/Important Bio-Agent (IBA)

3	Leukotriene B4IBA 04/2008 - 03/2006
3	Interleukin-13IBA 11/2006 - 02/2004
2	Histamine (Histamine Dihydrochloride)IBA 01/2008 - 12/2002
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 10/2003 - 09/2003
2	fexofenadine (Allegra)FDA LinkGeneric 10/2003 - 07/2002
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2008
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 04/2008
1	NF-kappa B (NF-kB)IBA 04/2008
1	Histamine H1 AntagonistsIBA 01/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008
1	rho guanine nucleotide exchange factors (rhoGEF)IBA 07/2007
1	Phosphotransferases (Kinase)IBA 06/2007
1	Fc Receptors (Fc Receptor)IBA 01/2007
1	Leukotriene E4IBA 09/2006
1	pirfenidoneIBA 09/2006
1	Complement Factor B (Factor B)IBA 05/2006
1	montelukast (Singulair)FDA Link 04/2006
1	ciclesonide FDA Link 03/2006
1	Immunoglobulin E (IgE)IBA 11/2005
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2005
1	NeuropeptidesIBA 04/2005
1	Immunoglobulins (Immunoglobulin)IBA 03/2005
1	Air Pollutants (Pollutants, Air)IBA 11/2004
1	AntibodiesIBA 05/2004
1	Thomsen-Friedenreich antibodiesIBA 05/2004
1	CytokinesIBA 03/2004
1	AntigensIBA 02/2004
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2002